Skip header and navigation

51 records – page 1 of 6.

Document Type
Evidence Search Report
Review Code
EOC011901-01 ESR
Question Submitted
January 19, 2021
Date Completed
January 21, 2021
Status
3. Completed
Research Team
EOC
ID: EOC011901-01 ESR Complete Date: January 21, 2021 Subject(s): Vaccination, Risk Assessment
Document Type
Evidence Search Report
Review Code
EOC011901-01 ESR
Question Submitted
January 19, 2021
Date Completed
January 21, 2021
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Subject
Vaccination
Risk
Infection Prevention and Control
Population
All adults
Clinical Setting
Community
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Mueller, M.; Young, C. How safe are the Pfizer and Moderna vaccinations? 2021 Jan 21; Document no.: EOC011901-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 31 p. (CEST evidence search report).
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC011901 RR
Question Submitted
January 19, 2021
Date Completed
January 24, 2021
Status
3. Completed
Research Team
EOC
the general rates for vaccines.  Various regulatory agencies identify the risk for serious allergic
Document Type
Rapid Review
Review Code
EOC011901 RR
Question Submitted
January 19, 2021
Date Completed
January 24, 2021
Status
3. Completed
Research Team
EOC
Key Findings
Initial findings from RCTs of the two authorized COVID-19 vaccines (Pfizer-BioNTech and Moderna) reported that the vaccines are safe. However, subsequent reports show that the adverse and severe allergic reactions to these vaccines are higher than the general rates for vaccines.
Various regulatory agencies identify the risk for serious allergic reactions as low for the authorized vaccines, and they continue to monitor the vaccines’ safety closely.
Further investigations to make causal relationships with reported severe allergic reactions or deaths are needed.
Risks and benefits of receiving the vaccines should be discussed individually in vulnerable populations including pregnant or breast-feeding women, immunocompromised people, or frail elderly people.
Category
Infection Prevention and Control
Subject
Vaccination
Risk
Infection Prevention and Control
Population
All adults
Clinical Setting
Community
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Azizian, A; Groot, G; Mueller, M; Young, C. How safe are the Pfizer and Moderna vaccinations? 2021 Jan 24; Document no.: EOC011901 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 30 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC040202-01 ESR
Question Submitted
April 2, 2020
Date Completed
April 2, 2020
Status
3. Completed
Research Team
EOC
of ICU" on pages 8-9 Risk of Transmission of COVID-19 (Coronavirus) Hamad International Training
Document Type
Evidence Search Report
Review Code
EOC040202-01 ESR
Question Submitted
April 2, 2020
Date Completed
April 2, 2020
Status
3. Completed
Research Team
EOC
Notes
No rapid review written.
Category
Infection Prevention and Control
Clinical Management
Subject
Risk
Personal Protective Equipment
Priority Level
Level 2 completed within 8 hours
Cite As
Howell-Spooner, B; Fox, L. Is it safe to perform CPR on patients with suspected or confirmed COVID-19 while using PPE? 2020 Apr 2; Document no.: EOC040202-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 13 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC082502-01 ESR
Question Submitted
August 25, 2020
Date Completed
August 27, 2020
Status
3. Completed
Research Team
EOC
Thermometers Used for COVID-19 Testing do not Pose Risk to Pineal Gland. July 28, 2020. https://apnews.com
Document Type
Evidence Search Report
Review Code
EOC082502-01 ESR
Question Submitted
August 25, 2020
Date Completed
August 27, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Infection Prevention and Control
Subject
Infrared Thermometers
Screening
Public Health
Risk
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Ellsworth, C; Fox, L. Is there evidence of risks for using infrared thermometers? 2020 Aug 27; Document no.: EOC082502-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 11 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC082502 RR
Question Submitted
August 25, 2020
Date Completed
August 29, 2020
Status
3. Completed
Research Team
EOC
with an LED tracker light, these are similar to those used in television remote controls and pose no risk
Document Type
Rapid Review
Review Code
EOC082502 RR
Question Submitted
August 25, 2020
Date Completed
August 29, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Infrared thermometers detect the infrared waves emitted by an object and convert into an electrical signal to display the distribution of temperature · Infrared thermometers do not emit radiation, however many are equipped with a laser tracker beam, similar to that found in television remote controls · The Pineal Gland is located deep inside the brain, separated from the forehead by the presence of the skull and several centimeters of brain tissue
Category
Administration
Infection Prevention and Control
Subject
Infrared Thermometers
Screening
Public Health
Risk
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Groot, G; Ellsworth, C; Fox, L. Is there evidence of risks for using infrared thermometers? 2020 Aug 29; Document no.: EOC082502 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
INF092801-01 ESR
Question Submitted
September 28, 2020
Date Completed
September 30, 2020
Status
3. Completed
Research Team
Infectious Disease
of Birmingham. COVID-19 Patients Who Undergo Surgery Are at Increased Risk of Postoperative Death – Global
Document Type
Evidence Search Report
Review Code
INF092801-01 ESR
Question Submitted
September 28, 2020
Date Completed
September 30, 2020
Status
3. Completed
Research Team
Infectious Disease
Category
Clinical Presentation
Subject
Mortality
Risk
Surgical Procedures
Population
All adults
Clinical Setting
Medicine Unit
Priority Level
Level 3 Two weeks (14 days)
Cite As
Howell-Spooner, B; Dalidowicz, M. Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients? 2020 Sep 30; Document no.: INF092801-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 41 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
INF092801 RR
Question Submitted
September 28, 2020
Date Completed
October 15, 2020
Status
3. Completed
Research Team
Infectious Disease
. Such outcomes provide a standard by which the relative risk of surgical procedures can be compared under
Document Type
Rapid Review
Review Code
INF092801 RR
Question Submitted
September 28, 2020
Date Completed
October 15, 2020
Status
3. Completed
Research Team
Infectious Disease
Key Findings
30-day mortality was consistently higher for surgical patients who tested positive for COVID-19
Advanced age (70+) was a major contributor to poorer post-surgical outcomes in COVID-positive patients
Morbidity, particularly with regard to pulmonary functioning, was higher in COVID-positive surgical patients
Category
Clinical Presentation
Subject
Mortality
Risk
Surgical Procedures
Population
All adults
Clinical Setting
Medicine Unit
Priority Level
Level 3 Two weeks (14 days)
Cite As
McCarron, M; Lee, S; Takaya, S; Howell-Spooner, B; Dalidowicz, M. Is there increased morbidity or mortality peri-operatively for symptomatic, asymptomatic, post-COVID patients? 2020 Oct 15; Document no.: INF092801 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 27 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Table
Review Code
EPM050901 RR Table
Question Submitted
May 9, 2020
Date Completed
May 19, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
ID Table Identification Table Associated Review Title: What are the risk factors for severity
Document Type
Table
Review Code
EPM050901 RR Table
Question Submitted
May 9, 2020
Date Completed
May 19, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
Category
Clinical Presentation
Subject
Comorbidities
Risk
Mortality
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Williams-Roberts, H; Groot, G; Dalidowicz, M; Young, C; Mueller, M. What are the risk factors for severity and death associated with COVID-19? 2020 May 17; Document no.: EPM050901 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. (CEST table)
Related Documents
Documents

EPM050901 RR Table

Download File
Less detail
Document Type
Rapid Review
Review Code
EOC210502 RR
Question Submitted
May 27, 2021
Date Completed
June 10, 2021
Status
3. Completed
Research Team
EOC
the potential benefit clearly outweighs the risk of administration”. These are not considered to be absolute
Document Type
Rapid Review
Review Code
EOC210502 RR
Question Submitted
May 27, 2021
Date Completed
June 10, 2021
Status
3. Completed
Research Team
EOC
Key Findings
Only agreed upon contraindications against COVID-19 vaccination is for individuals with a history of allergic reactions to a component of the vaccine or an allergic reaction to a previous dose
Where allergies to components exist, vaccination with an alternative COVID-19 vaccine should be considered
Autoimmune conditions and treatments are not considered contraindications, however timing of vaccines in relation to treatment regimens should be considered
Category
Administration
Subject
Vaccination
Decision Making
Risk
Population
All
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Groot, G; Reeder, B; Young, C; Ellsworth, C. What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view? 2021 Jun 10, Document no.: EOC210502 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. 8 p. (CEST rapid review report).
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC100801-01 ESR
Question Submitted
October 8, 2020
Date Completed
October 13, 2020
Status
3. Completed
Research Team
EOC
of vulnerability has been extended and additional at-risk groups may be identified over time, so it is important
Document Type
Evidence Search Report
Review Code
EOC100801-01 ESR
Question Submitted
October 8, 2020
Date Completed
October 13, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Subject
Risk
Elderly
Facilities
Health Personnel
Population
Aged (80+)
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Miller, L; Mueller, M. What are the age restrictions for healthcare workers/volunteers? 2020 Oct 13; Document no.: EOC100801-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 5 p. (CEST evidence search report)
Related Documents
Documents
Less detail

51 records – page 1 of 6.